Optimal medical treatment versus endovascular aortic repair in uncomplicated isolated abdominal aortic dissection

医学 四分位间距 外科 主动脉夹层 回顾性队列研究 单变量分析 解剖(医学) 主动脉修补术 病历 腹部外科 动脉瘤 内科学 主动脉 多元分析
作者
Sheng Su,Jitao Liu,Changjin Wang,Rui-Rong Chen,Yuanli Liu,Wenhui Huang,Songyuan Luo,Fan Yang,Jianfang Luo
出处
期刊:Journal of Vascular Surgery [Elsevier]
卷期号:77 (4): 1028-1036.e2
标识
DOI:10.1016/j.jvs.2022.10.036
摘要

To report the results of optimal medical treatment (OMT) and endovascular aortic repair (EVAR) in patients with uncomplicated isolated abdominal aortic dissection (IAAD).A retrospective review of 96 consecutive patients with uncomplicated IAAD (uIAAD) managed at a single tertiary vascular unit between January 2011 and July 2021 was conducted. Standard methods for univariate and survival analyses were used. The primary outcomes were all-cause mortality. Secondary end points included uIAAD progression, interventional complications, and follow-up aortic intervention.Initially, 53.1% of patients (51/96) were managed with OMT. No in-hospital deaths occurred. During follow-up, three patients died, and three and two patients who were initially managed with OMT subsequently required endovascular treatment and surgical management, respectively. Initially, 46.9% of patients (45/96) underwent EVAR. One patient died during hospital admission; nine patients had an endoleak after operation and one needed reintervention. Furthermore, during follow-up, five patients died; four patients needed reoperation, one surgery and three endovascular treatments. The overall long-term mortality was 8.4%, and follow-up aortic intervention rate was 9.5% (median follow-up, 54 months; interquartile range, 33-81 months) with no significant difference between groups. Of note, 12 patients (12.6%) suffered uIAAD progression, which was higher in the OMT group than EVAR group (10 [19.6%] vs 2 [4.5%]; P = .03).uIAAD may be managed safely by OMT with regular surveillance, despite the risk of disease progression. Compared with OMT, EVAR could significantly prevent uIAAD progression. For anatomically suitable patients with uIAAD progression and who are unresponsive to OMT, pre-emptive EVAR is a safe and feasible option.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
罗先生完成签到,获得积分20
刚刚
李健应助LZNUDT采纳,获得10
刚刚
放飞的羊驼完成签到,获得积分10
1秒前
2秒前
君无邪完成签到,获得积分10
2秒前
上官若男应助现代的谷南采纳,获得10
2秒前
3秒前
3秒前
小鹿呀完成签到,获得积分10
3秒前
syc发布了新的文献求助10
3秒前
含糊的丹彤完成签到,获得积分10
4秒前
Owen应助科研通管家采纳,获得10
4秒前
个性的荆应助科研通管家采纳,获得10
4秒前
浮游应助科研通管家采纳,获得10
4秒前
Zeee发布了新的文献求助10
4秒前
斯文败类应助科研通管家采纳,获得10
4秒前
个性的荆应助科研通管家采纳,获得10
4秒前
浮游应助科研通管家采纳,获得10
4秒前
斯文败类应助科研通管家采纳,获得10
5秒前
酷波er应助科研通管家采纳,获得10
5秒前
李爱国应助科研通管家采纳,获得10
5秒前
浮游应助科研通管家采纳,获得10
5秒前
英姑应助科研通管家采纳,获得10
5秒前
充电宝应助徐嘉采纳,获得10
5秒前
5秒前
华仔应助科研通管家采纳,获得30
5秒前
5秒前
5秒前
asdfzxcv应助科研通管家采纳,获得150
5秒前
5秒前
科研通AI6应助sss采纳,获得10
5秒前
5秒前
研友_VZG7GZ应助科研通管家采纳,获得10
5秒前
zzz完成签到,获得积分10
5秒前
浮游应助科研通管家采纳,获得10
5秒前
个性的荆应助科研通管家采纳,获得10
5秒前
甜蜜妙竹发布了新的文献求助10
5秒前
Orange应助乌妮卡布兹采纳,获得10
6秒前
6秒前
浮游应助李_Steven采纳,获得10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Binary Alloy Phase Diagrams, 2nd Edition 8000
Encyclopedia of Reproduction Third Edition 3000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
From Victimization to Aggression 1000
Translanguaging in Action in English-Medium Classrooms: A Resource Book for Teachers 700
Exosomes Pipeline Insight, 2025 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5652390
求助须知:如何正确求助?哪些是违规求助? 4787308
关于积分的说明 15059776
捐赠科研通 4810983
什么是DOI,文献DOI怎么找? 2573527
邀请新用户注册赠送积分活动 1529357
关于科研通互助平台的介绍 1488250